Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$1.07B |
| 2 |
Cisco
CSCO
|
+$871M |
| 3 |
Alibaba
BABA
|
+$729M |
| 4 |
Booking.com
BKNG
|
+$567M |
| 5 |
Ventas
VTR
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.52B |
| 2 |
Yum! Brands
YUM
|
+$923M |
| 3 |
Biogen
BIIB
|
+$904M |
| 4 |
Oracle
ORCL
|
+$823M |
| 5 |
BHI
Baker Hughes
BHI
|
+$597M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.41% |
| 2 | Technology | 12.87% |
| 3 | Industrials | 11.05% |
| 4 | Communication Services | 10.38% |
| 5 | Consumer Staples | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENH
276
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $112M | 0.04% |
2,036,000
| – | – |
|
277
WEX
WEX
$6.48B
| $112M | 0.04% |
1,014,162
+773,162
| +321% | +$84.9M |
|
|
RDS.B
278
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $111M | 0.04% |
1,397,800
| – | – |
|
|
BIG
279
DELISTED
Big Lots, Inc.
BIG
| $106M | 0.04% |
2,469,800
| – | – |
|
|
MRSH
280
Marsh
MRSH
$90.1B
| $105M | 0.04% |
2,000,000
-1,000,000
| -33% | -$52.1M |
|
|
EVHC
281
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $104M | 0.04% |
1,002,000
+668,000
| +200% | +$70.9M |
|
|
TIF
282
DELISTED
Tiffany & Co.
TIF
| $103M | 0.04% |
1,069,265
-600,000
| -36% | -$59.8M |
|
283
Arista Networks
ANET
$265B
| $102M | 0.04% |
18,549,264
-770,656
| -4% | -$3.66M |
|
|
TMX
284
DELISTED
Terminix Global Holdings, Inc.
TMX
| $102M | 0.04% |
+6,299,540
| New | +$90.6M |
|
285
National Grid
NGG
$81.1B
| $102M | 0.04% |
1,464,206
| – | – |
|
286
Penske Automotive Group
PAG
$14.3B
| $99M | 0.03% |
2,439,000
-268,000
| -10% | -$12.6M |
|
|
CRAY
287
DELISTED
Cray, Inc.
CRAY
| $98.8M | 0.03% |
3,763,472
| – | – |
|
|
B
288
Barrick Mining
B
$67.9B
| $97.8M | 0.03% |
6,669,100
-3,600,000
| -35% | -$64.2M |
|
|
WW
289
DELISTED
WW International
WW
| $96.9M | 0.03% |
3,532,000
-555,000
| -14% | -$12.7M |
|
|
NATI
290
DELISTED
National Instruments Corp
NATI
| $96.9M | 0.03% |
3,132,764
| – | – |
|
291
Globe Life
GL
$13.8B
| $94.3M | 0.03% |
1,800,000
| – | – |
|
|
EXAS
292
DELISTED
Exact Sciences
EXAS
| $93.6M | 0.03% |
4,829,214
+1,452,392
| +43% | +$26.6M |
|
293
United Airlines
UAL
$40.6B
| $93.6M | 0.03% |
1,999,996
-2,951,600
| -60% | -$137M |
|
294
Toronto Dominion Bank
TD
$204B
| $92.9M | 0.03% |
1,883,000
| – | – |
|
295
Avient
AVNT
$4.16B
| $91.5M | 0.03% |
2,572,168
| – | – |
|
296
Texas Capital Bancshares
TCBI
$4.38B
| $91M | 0.03% |
1,577,715
-766,085
| -33% | -$41.3M |
|
|
DCUC
297
DELISTED
Dominion Energy, Inc.
DCUC
| $89.8M | 0.03% |
+1,800,000
| New | +$91.6M |
|
298
KBR
KBR
$4.8B
| $89.3M | 0.03% |
4,745,000
| – | – |
|
299
Brinker International
EAT
$10.5B
| $88.2M | 0.03% |
1,737,500
+100,000
| +6% | +$4.8M |
|
300
Boeing
BA
$183B
| $79.6M | 0.03% |
625,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2014 Portfolio in Review
As of Q3 2014, Capital Research Global Investors held 464 positions worth $289B, up 1% from $286B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q3 2014 filing shows 29 new, 121 increased, 131 reduced and 23 closed positions. Its largest new stake was Alibaba: 8,115,335 shares worth $721M. The largest sale was Gilead Sciences, an estimated $1.52B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Capital Research Global Investors's largest Q3 2014 buy was Alibaba: 8,115,335 shares worth $721M.
- Capital Research Global Investors added most to Monsanto Co in Q3 2014, an estimated $1.07B increase.
- Capital Research Global Investors's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $1.52B.
- Capital Research Global Investors fully exited OPENTABLE,INC COMMON STOCK in Q3 2014, selling an estimated $155M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $289B portfolio in Q3 2014.
- Capital Research Global Investors opened 29 new positions and closed 23 in Q3 2014.
- Capital Research Global Investors's portfolio value rose 1% quarter-over-quarter to $289B.
Based on Capital Research Global Investors's 13F filing for Q3 2014, filed 14 Nov 2014.